Emmett V. Schmidt

Emmett V. Schmidt

Company: Merck and Co

Job title: Vice President, Clinical Research Lead, External Collaborations Oncology Early Development


Independent Action, Collateral Sensitivity, & Directions For Future Progress For Immune Checkpoint Inhibitors in NSCLC 8:00 am

What is old is still true: current approved immune checkpoint inhibitor combinations depend on combinations of orthogonal cancer therapies according to principles of independent activity The future is here: The emerging landscape of post-PD-1 treatment trials What is old is still true: A reminder of collateral sensitivity as a historic combination principleRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.